Page last updated: 2024-12-08

strictosidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID161336
CHEMBL ID402211
CHEBI ID17559
SCHEMBL ID8322946
MeSH IDM0075557

Synonyms (26)

Synonym
CHEBI:17559 ,
3alpha(s)-strictosidine
methyl (2s,3r,4s)-3-ethenyl-2-(beta-d-glucopyranosyloxy)-4-[(1s)-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indol-1-ylmethyl]-3,4-dihydro-2h-pyran-5-carboxylate
20824-29-7
C03470
3-alpha(s)-strictosidine
strictosidine ,
CHEMBL402211
methyl (2s,3r,4s)-3-ethenyl-4-[[(1s)-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indol-1-yl]methyl]-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2h-pyran-5-carboxylate
isovincoside
(2s-(2alpha,3beta,4beta(r*)))-3-ethenyl-2-(beta-d-glucopyranosyloxy)-3,4-dihydro-4-((2,3,4,9-tetrahydro-1h-pyrido(3,4-b)indol-1-yl) methyl)-2h-pyran-5-carboxylic acid, methyl ester
45t874r5n4 ,
2h-pyran-5-carboxylic acid, 3-ethenyl-2-(beta-d-glucopyranosyloxy)-3,4-dihydro-4-((2,3,4,9-tetrahydro-1h-pyrido(3,4-b)indol-1-yl)methyl)-, methyl ester, (2s-(2alpha,3beta,4beta(r*)))-
unii-45t874r5n4
SCHEMBL8322946
HY-124165
CS-0084513
DTXSID40943068
Q2356148
(2s,3r,4s)-methyl 4-(((s)-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indol-1-yl)methyl)-2-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-3-vinyl-3,4-dihydro-2h-pyran-5-carboxylate
strictosidin
methyl (4s,5r,6s)-5-ethenyl-4-{[(1s)-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indol-1-yl]methyl}-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate
3-isovincoside
(-)-strictosidine
AKOS040762379
FS-7040

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (4)

ClassDescription
indole alkaloidAn alkaloid containing an indole skeleton.
alkaloid ester
beta-D-glucosideAny D-glucoside in which the anomeric centre has beta-configuration.
methyl esterAny carboxylic ester resulting from the formal condensation of a carboxy group with methanol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (5)

PathwayProteinsCompounds
Indole Alkaloid Biosynthesis311
camptothecin biosynthesis09
ajmaline and sarpagine biosynthesis137
secologanin and strictosidine biosynthesis332
vindoline, vindorosine and vinblastine biosynthesis240
Secologanin and strictosidine biosynthesis015

Protein Targets (1)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID331127Activity of Catharanthus roseus strictosidine glucosidase2008Bioorganic & medicinal chemistry letters, May-15, Volume: 18, Issue:10
Substrate specificity and diastereoselectivity of strictosidine glucosidase, a key enzyme in monoterpene indole alkaloid biosynthesis.
AID331128Ratio of relative Vmax to K0.5 of Catharanthus roseus strictosidine glucosidase2008Bioorganic & medicinal chemistry letters, May-15, Volume: 18, Issue:10
Substrate specificity and diastereoselectivity of strictosidine glucosidase, a key enzyme in monoterpene indole alkaloid biosynthesis.
AID356161DNA damaging activity in yeast RS 322YK mutant assessed as drug level required to produce 12 mm zone of inhibition2003Journal of natural products, Jul, Volume: 66, Issue:7
Turbinatine, a potential key intermediate in the biosynthesis of corynanthean-type indole alkaloids.
AID333567Antioxidant activity assessed as DPPH radical scavenging activity2004Journal of natural products, Nov, Volume: 67, Issue:11
Indole glucoalkaloids from Chimarrhis turbinata and their evaluation as antioxidant agents and acetylcholinesterase inhibitors.
AID356162DNA damaging activity in yeast RS 188N mutant assessed as drug level required to produce 12 mm zone of inhibition2003Journal of natural products, Jul, Volume: 66, Issue:7
Turbinatine, a potential key intermediate in the biosynthesis of corynanthean-type indole alkaloids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (49)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (6.12)18.7374
1990's1 (2.04)18.2507
2000's14 (28.57)29.6817
2010's17 (34.69)24.3611
2020's14 (28.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.04 (24.57)
Research Supply Index3.93 (2.92)
Research Growth Index5.38 (4.65)
Search Engine Demand Index44.79 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other45 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]